{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:52:24Z","timestamp":1794271944326,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Studies have investigated risk factors for infections by specific species of carbapenem-resistant Gram-negative bacilli (CR-GNB), but few considered the group of GNB species and most of them were performed in the setting of bacteremia or hospital infection. This study was implemented to identify risk factors for sepsis by CR- and carbapenem-susceptible (CS) GNB in intensive care unit (ICU) patients to improve management strategies for CR-GNB sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We developed a case-case-control study from a prospective cohort of patients with systemic inflammatory response syndrome (SIRS), sepsis-2 or sepsis-3 criteria in which blood and other sample cultures were collected and antimicrobial therapy was instituted, in an adult clinical-surgical ICU, at tertiary public hospital in Rio de Janeiro, from August 2015 through March 2017.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the total of 629 ICU admissions followed by 7797 patient-days, after applying inclusion and exclusion criteria we identified 184 patients who developed recurrent or single hospital-acquired sepsis. More than 90% of all evaluable cases of sepsis and 87% of control group fulfilled the modified sepsis-3 definition. Non-fermenting bacilli and ventilator-associated pneumonia predominated as etiology and source of CR-GNB sepsis. While Enterobacteriaceae and intra-abdominal surgical site plus urinary-tract infections prevailed in CS-GNB than CR-GNB sepsis. Carbapenemase production was estimated in 76% of CR-GNB isolates. Multivariate logistic regression analysis revealed previous infection (mostly hospital-acquired bacterial infection or sepsis) (OR\u2009=\u20094.28; 95% CI 1.77\u201310.35), mechanical ventilation (OR\u2009=\u20094.21; 95% CI 1.17\u201315.18), carbapenem use (OR\u2009=\u20093.42; 95% CI 1.37\u20138.52) and length of hospital stay (OR\u2009=\u20091.03; 95% CI 1.01\u20131.05) as independent risk factors for sepsis by CR-GNB. While ICU readmission (OR\u2009=\u20096.92; 95% CI 1.72\u201327.78) and nosocomial diarrhea (OR\u2009=\u20095.32; 95% CI 1.07\u201326.45) were factors associated with CS-GNB sepsis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The investigation of recurrent and not only bacteremic episodes of sepsis was the differential of this study. The results are in agreement with the basic information in the literature. This may help improve management strategies and future studies on sepsis by CR-GNB.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13756-020-00791-w","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T13:03:00Z","timestamp":1597410180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study"],"prefix":"10.1186","volume":"9","author":[{"given":"Elisangela M.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia A.","family":"Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora S.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Henrique Z.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedro S.","family":"Tonh\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio Z. O.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Newton D.","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Q.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marise D.","family":"Asensi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Aur\u00e9lio","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina S.","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Augusto S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saint Clair S.","family":"Gomes Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-1034","authenticated-orcid":false,"given":"Marisa Z. R.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Nucleus of Hospital Research study collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00f3ria Regina A. A.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila P.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scyla Maria S. A. S.","family":"Reis Di Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda Aparecida S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaisa M.","family":"Tozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas Lameir\u00e3o P. A.","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo C. M.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wania V.","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula D. C.","family":"Assef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"791_CR1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/EJA.0b013e3283333aac","volume":"27","author":"A Braber","year":"2010","unstructured":"Braber A, van Zanten AR. Unravelling post-ICU mortality: predictors and causes of death. Eur J Anaesthesiol. 2010;27:486\u201390.","journal-title":"Eur J Anaesthesiol"},{"key":"791_CR2","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/cc10114","volume":"15","author":"JR Prowle","year":"2011","unstructured":"Prowle JR, Echeverri JE, Ligabo EV, Sherry N, Taori GC, Crozier TM, et al. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality. Crit Care. 2011;15:R100.","journal-title":"Crit Care"},{"key":"791_CR3","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1086\/432803","volume":"41","author":"R Gaynes","year":"2005","unstructured":"Gaynes R, Edwards JR. National Nosocomial Infections Surveillance S. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005;41:848\u201354.","journal-title":"Clin Infect Dis"},{"key":"791_CR4","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00134-012-2695-9","volume":"38","author":"A Tabah","year":"2012","unstructured":"Tabah A, Koulenti D, Laupland K, Misset B, Valles J, de Bruzzi CF, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT. Intensive Care Med. 2012;38:1930\u201345.","journal-title":"Intensive Care Med"},{"key":"791_CR5","doi-asserted-by":"crossref","unstructured":"Luna CM, Rodriguez-Noriega E, Bavestrello L, Guzman-Blanco M. Gram-negative infections in adult intensive care units of latin america and the Caribbean. Crit Care Res Pract. 2014. Article ID 480463, 12 pages. http:\/\/dx.doi.org\/10.1155\/2014\/480463.","DOI":"10.1155\/2014\/480463"},{"key":"791_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10096-017-3098-1","volume":"37","author":"E Kousouli","year":"2018","unstructured":"Kousouli E, Zarkotou O, Politi L, Polimeri K, Vrioni G, Themeli-Digalaki K, et al. Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens. Eur J Clin Microbiol Infect Dis. 2018;37:43\u201350.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"791_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/S1413-86702009000500005","volume":"13","author":"RM Romanelli","year":"2009","unstructured":"Romanelli RM, Jesus LA, Clemente WT, Lima SS, Rezende EM, Coutinho RL, et al. Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control. Braz J Infect Dis. 2009;13:341\u20137.","journal-title":"Braz J Infect Dis"},{"key":"791_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s15010-010-0008-1","volume":"38","author":"C Routsi","year":"2010","unstructured":"Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V, et al. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection. 2010;38:173\u201380.","journal-title":"Infection."},{"key":"791_CR9","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1016\/j.ijid.2010.02.2254","volume":"14","author":"WH Sheng","year":"2010","unstructured":"Sheng WH, Liao CH, Lauderdale TL, Ko WC, Chen YS, Liu JW, et al. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii. Int J Infect Dis. 2010;14:e764\u20139.","journal-title":"Int J Infect Dis"},{"key":"791_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1590\/S1413-86702012000300001","volume":"16","author":"MZ Gomes","year":"2012","unstructured":"Gomes MZ, Oliveira RV, Machado CR, Conceicao Mde S, Souza CV, Lourenco MC, et al. Factors associated with epidemic multiresistant Pseudomonas aeruginosa infections in a hospital with AIDS-predominant admissions. Braz J Infect Dis. 2012;16:219\u201325.","journal-title":"Braz J Infect Dis"},{"key":"791_CR11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1099\/jmm.0.073262-0","volume":"63","author":"RC Dantas","year":"2014","unstructured":"Dantas RC, Ferreira ML, Gontijo-Filho PP, Ribas RM. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome. J Med Microbiol. 2014;63:1679\u201387.","journal-title":"J Med Microbiol"},{"key":"791_CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.25100\/cm.v45i2.1417","volume":"45","author":"V Gomez Rueda","year":"2014","unstructured":"Gomez Rueda V, Zuleta Tobon JJ. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study. Colomb Med (Cali). 2014;45:54\u201360.","journal-title":"Colomb Med (Cali)"},{"key":"791_CR13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jiac.2013.11.007","volume":"20","author":"DP Kofteridis","year":"2014","unstructured":"Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection\/colonization: a case-case-control study. J Infect Chemother. 2014;20:293\u20137.","journal-title":"J Infect Chemother"},{"key":"791_CR14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajic.2013.09.003","volume":"42","author":"ES Ozgur","year":"2014","unstructured":"Ozgur ES, Horasan ES, Karaca K, Ersoz G, Nayci Atis S, Kaya A. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. Am J Infect Control. 2014;42:206\u20138.","journal-title":"Am J Infect Control"},{"key":"791_CR15","doi-asserted-by":"crossref","first-page":"e0123337","DOI":"10.1371\/journal.pone.0123337","volume":"10","author":"P de Jager","year":"2015","unstructured":"de Jager P, Chirwa T, Naidoo S, Perovic O, Thomas J. Nosocomial outbreak of New Delhi Metallo-beta-Lactamase-1-producing gram-negative bacteria in South Africa: a case-control study. PLoS One. 2015;10:e0123337.","journal-title":"PLoS One"},{"key":"791_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.12659\/MSM.892516","volume":"21","author":"A Candevir Ulu","year":"2015","unstructured":"Candevir Ulu A, Kurtaran B, Inal AS, Komur S, Kibar F, Yapici Cicekdemir H, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit. 2015;21:219\u201324.","journal-title":"Med Sci Monit"},{"key":"791_CR17","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s10096-016-2710-0","volume":"35","author":"Q Wang","year":"2016","unstructured":"Wang Q, Zhang Y, Yao X, Xian H, Liu Y, Li H, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis. 2016;35:1679\u201389.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"791_CR18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00134-013-2914-z","volume":"39","author":"C Routsi","year":"2013","unstructured":"Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Papas V, Pitsiolis T, et al. Risk factors for carbapenem-resistant gram-negative bacteremia in intensive care unit patients. Intensive Care Med. 2013;39:1253\u201361.","journal-title":"Intensive Care Med"},{"key":"791_CR19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jmii.2016.08.022","volume":"51","author":"SW Ting","year":"2018","unstructured":"Ting SW, Lee CH, Liu JW. Risk factors and outcomes for the acquisition of carbapenem-resistant gram-negative bacillus bacteremia: a retrospective propensity-matched case control study. J Microbiol Immunol Infect. 2018;51:621\u20138.","journal-title":"J Microbiol Immunol Infect"},{"key":"791_CR20","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4:e296.","journal-title":"PLoS Med"},{"key":"791_CR21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA."},{"key":"791_CR22","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS international Sepsis definitions conference. Crit Care Med. 2003;31:1250\u20136.","journal-title":"Crit Care Med"},{"key":"791_CR23","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/CCM.0b013e3182923712","volume":"41","author":"PM Klein Klouwenberg","year":"2013","unstructured":"Klein Klouwenberg PM, Ong DS, Bos LD, de Beer FM, van Hooijdonk RT, Huson MA, et al. Interobserver agreement of Centers for Disease Control and Prevention criteria for classifying infections in critically ill patients. Crit Care Med. 2013;41:2373\u20138.","journal-title":"Crit Care Med"},{"key":"791_CR24","volume-title":"National Healthcare Safety Network (NHSN) Patient Safety Component Manual","author":"CDC","year":"2017","unstructured":"CDC. National Healthcare Safety Network (NHSN) Patient Safety Component Manual. 2017: https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pcsmanual_current.pdf. Accessed 16 June 2018."},{"key":"791_CR25","unstructured":"CLSI. Twentieth eighth informational supplement. CLSI document M100-Ed28. Wayne,PA: Clinical laboratory Standards Institute; 2018. Accessed 16 June 2018."},{"key":"791_CR26","unstructured":"EUCAST. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 8.1, valid from 2018-05-15 http:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed 16 June 2018."},{"key":"791_CR27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijantimicag.2008.12.009","volume":"34","author":"KR Carvalho","year":"2009","unstructured":"Carvalho KR, Carvalho-Assef AP, Peirano G, Santos LC, Pereira MJ, Asensi MD. Dissemination of multidrug-resistant Acinetobacter baumannii genotypes carrying Bla (OXA-23) collected from hospitals in Rio de Janeiro, Brazil. Int J Antimicrob Agents. 2009;34:25\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"791_CR28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.diagmicrobio.2011.01.006","volume":"70","author":"LM Seki","year":"2011","unstructured":"Seki LM, Pereira PS, de Souza MP, Conceicao Mde S, Marques EA, Porto CO, et al. Molecular epidemiology of KPC-2- producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437. Diagn Microbiol Infect Dis. 2011;70:274\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"791_CR29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"key":"791_CR30","unstructured":"Rosner BR. Fundamentals of Biostatistics. 8th ed. Mason: Cengage Learning; 2015."},{"key":"791_CR31","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression. 3rd ed. New York: Wiley; 2013.","DOI":"10.1002\/9781118548387"},{"key":"791_CR32","doi-asserted-by":"crossref","unstructured":"Henley SS, Golden RM, Kashner TM. Statistical modeling methods: challenges and strategies. Biostatistics Epidemiol. 2019:1\u201335.","DOI":"10.1080\/24709360.2019.1618653"},{"key":"791_CR33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccc.2006.02.006","volume":"22","author":"DN Fish","year":"2006","unstructured":"Fish DN, Ohlinger MJ. Antimicrobial resistance: factors and outcomes. Crit Care Clin. 2006;22:291\u2013311.","journal-title":"Crit Care Clin"},{"key":"791_CR34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cmi.2014.08.001","volume":"21","author":"S Amit","year":"2015","unstructured":"Amit S, Mishali H, Kotlovsky T, Schwaber MJ, Carmeli Y. Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. Clin Microbiol Infect. 2015;21:30\u20134.","journal-title":"Clin Microbiol Infect"},{"key":"791_CR35","first-page":"336","volume":"73","author":"MJ Satlin","year":"2016","unstructured":"Satlin MJ, Cohen N, Ma KC, Gedrimaite Z, Soave R, Askin G, et al. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies. J Inf Secur. 2016;73:336\u201345.","journal-title":"J Inf Secur"},{"key":"791_CR36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1128\/AAC.01927-15","volume":"60","author":"M Falcone","year":"2016","unstructured":"Falcone M, Russo A, Iraci F, Carfagna P, Goldoni P, Vullo V, et al. Risk factors and outcomes for bloodstream infections secondary to Clostridium difficile infection. Antimicrob Agents Chemother. 2016;60:252\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"791_CR37","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3). Jama. 2016;315:762\u201374.","journal-title":"Jama."},{"key":"791_CR38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmi.2016.11.003","volume":"23","author":"EJ Giamarellos-Bourboulis","year":"2017","unstructured":"Giamarellos-Bourboulis EJ, Tsaganos T, Tsangaris I, Lada M, Routsi C, Sinapidis D, et al. Validation of the new Sepsis-3 definitions: proposal for improvement in early risk identification. Clin Microbiol Infect. 2017;23:104\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"791_CR39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/1471-2334-14-489","volume":"14","author":"JF Timsit","year":"2014","unstructured":"Timsit JF, Soubirou JF, Voiriot G, Chemam S, Neuville M, Mourvillier B, et al. Treatment of bloodstream infections in ICUs. BMC Infect Dis. 2014;14:489.","journal-title":"BMC Infect Dis"},{"key":"791_CR40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/21505594.2015.1134072","volume":"7","author":"M Bassetti","year":"2016","unstructured":"Bassetti M, Righi E, Carnelutti A. Bloodstream infections in the intensive care unit. Virulence. 2016;7:267\u201379.","journal-title":"Virulence."},{"key":"791_CR41","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1086\/319600","volume":"32","author":"AD Harris","year":"2001","unstructured":"Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis. 2001;32:1055\u201361.","journal-title":"Clin Infect Dis"},{"key":"791_CR42","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/502550","volume":"26","author":"KS Kaye","year":"2005","unstructured":"Kaye KS, Harris AD, Samore M, Carmeli Y. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol. 2005;26:346\u201351.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"791_CR43","doi-asserted-by":"crossref","first-page":"e112208","DOI":"10.1371\/journal.pone.0112208","volume":"9","author":"G Hotta","year":"2014","unstructured":"Hotta G, Matsumura Y, Kato K, Nakano S, Yunoki T, Yamamoto M, et al. Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species. PLoS One. 2014;9:e112208.","journal-title":"PLoS One"},{"key":"791_CR44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","volume":"20","author":"AM Queenan","year":"2007","unstructured":"Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440\u201358 table of contents.","journal-title":"Clin Microbiol Rev"},{"key":"791_CR45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1586\/eri.09.108","volume":"8","author":"AP Zavascki","year":"2010","unstructured":"Zavascki AP, Carvalhaes CG, Picao RC, Gales AC. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti-Infect Ther. 2010;8:71\u201393.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"791_CR46","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","volume":"17","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17:1791\u20138.","journal-title":"Emerg Infect Dis"},{"key":"791_CR47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jgar.2013.01.005","volume":"1","author":"K Bush","year":"2013","unstructured":"Bush K. Carbapenemases: partners in crime. J Glob Antimicrob Resist. 2013;1:7\u201316.","journal-title":"J Glob Antimicrob Resist"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00791-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-020-00791-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00791-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T23:24:25Z","timestamp":1667777065000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00791-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["791"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00791-w","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]},"assertion":[{"value":"17 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by FIOCRUZ and HFSE Ethics Committees (CAAE: 39978114.5.0000.5248 and CAAE 39978114.5.3002.5252).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"132"}}